LISAvienna at #PragueBio Conference 2025 - Austria was also strongly represented. Did you know that Christine Ruckenbauer showcased RIANA Therapeutics – and took first place in the pitch competition? Congratulations! www.linkedin.com/feed/update/...

Last week we had the pleasure to attend the SLAS (Society for Laboratory Automation and Screening) regional meet-up at the @viennabiocenter.bsky.social. Save the date for SLAS Europe 2026 in Vienna next year: May 19-21, and sign up for the conference mailing list. www.linkedin.com/feed/update/...

Erfahren Sie in der neuen Transkript-Ausgabe mehr darüber, warum die Welt Anfang November nach Wien schaut. #BIOEurope pdf zum Download: www.lisavienna.at/fileadmin/us...

Learn more about the reimbursement of digital health applications across Europe at LISAvienna's #REG25 conference, Vienna, 15.10.2025 - Session A3 with AIHTA, IHS, HelloBetter, AUSTROMED www.linkedin.com/posts/lisavi...

ÖGMBT announced the Austrian Life Science Award 2025 Winners - congratulations!! www.linkedin.com/posts/oegmbt...

Highlight for delegates joining #BIOEurope 2025 in Vienna: Exclusive site visit to the Pharma & Life Science Park Orth on November 5 - organized by Infrareal. Seats are limited, sign up as soon as possbile after completing your conference registration www.linkedin.com/feed/update/...

LISAvienna’s September newsletter is out now! Catch up on the latest updates on news, events, and funding opportunities from Vienna’s life sciences ecosystem. www.linkedin.com/feed/update/...

Highlight at Takeda: Official launch of the company's new Advanced Heat Pump Demonstrator #AHEAD at the manufacturing site in Vienna, Austria - setting a new benchmark for more environmentally sustainable drug production. lnkd.in/p/dTPQrQTr

Glückwunsch an die prämierten Innovator*innen der BOKU, weiter so!

Dachgleiche des Eric Kandel Instituts - Zentrum für Präzisionsmedizin in Wien: Damit wurde ein wichtiger Meilenstein für die Zukunft der Life Sciences in Österreich gefeiert - Herzlichen Glückwunsch!

#Fördercalls Das #BMIMI stellt mit der #FFG rund 5 Mio Euro für die Förderschiene ‘Markt.Einstieg’ zur Verfügung, um die Verwertung von marktfähigen Prototypen zu beschleunigen, Marktrisiken abzufedern & so die Wettbewerbsfähigkeit & Innovationskraft des Standorts Österreich nachhaltig zu stärken. 🌱

„An. Aus. An. Aus.“ – So funktioniert Forschung nicht. Unsere Geschäftsführerin Elvira Welzig warnt im @KURIER vor kurzfristiger Forschungsfinanzierung. Wer auf Spitzenforschung setzt, muss Verlässlichkeit schaffen.

We’re thrilled to announce that the "High-Content CRISPR Screening" conference will take place on March 18–19, 2026, in Vienna, Austria. The registration is now open via the conference website: lnkd.in/d8KACZy5 Meet the Speaker: Luke Gilbert

Congrats to Anna Obenauf for receiving the Dr. Josef Steiner Cancer Research Award endowed with 1 million Swiss francs and originally referred to as the Nobel Prize for Cancer Research @obenaufa.bsky.social @impvienna.bsky.social @viennabiocenter.bsky.social mediarelations.unibe.ch/media_releas...

Did you know that @impvienna.bsky.social celebrates its 40th anniversary? Hghlight: Presentation of the Max Birnstiel Awards, which honour outstanding doctoral research in molecular life sciences. www.imp.ac.at/research/con... @viennabiocenter.bsky.social

Explore @meduniwien.ac.at's structural expansion, a historic investment that will guide and inspire generations of Austrian physicians for years to come. link.springer.com/article/10.1...

💯 Meilenstein in der Behandlung von #Autoimmunerkrankungen: #MedUniWien & #AKHWien haben erstmals in Österreich einen Patienten mit inhouse-hergestellten #CARTZellen#Autoimmunerkrankunggegen eine schwere #Autoimmunerkrankung behandelt. Mehr erfahren! ⬇️

Wusstet ihr, dass es in Wien fast 59.000 Hunde und 456 Wildbienenarten gibt? 🐝 Oder dass 75 % aller Gurken und 61 % aller Melanzani aus Österreich in Wien produziert werden? Diese und weitere Fakten findet ihr in der aktuellen Broschüre „Wien in Zahlen": https://www.wien.gv.at/statistik/

Exciting news! We're thrilled to announce the six outstanding laureates of the International Birnstiel Award for Doctoral Studies in Molecular Life Sciences 2025! 🏆Congratulations to all awardees and honourable mentions! 🎉 1/ ➡️ www.imp.ac.at/news/article...

Join our campus! The Vienna BioCenter PhD program offers 20+ fully-funded positions: Open call now! Read more: www.vbcphd.at Our working language is English #viennabiocenter #vbcphd

⏳ The deadline for IHI call 11 is in 1 MONTH! 🙋‍♂️ When finalising your proposal, make sure you have understood and addressed the requirements of the call text and the IHI rules. 📚 Need a refresher? Visit our IHI call 11 page - europa.eu/!64JV3K #IHITransformingHealth #HorizonEU #HealthResearch

Wie können naturwissenschaftliche Sammlungen in Österreich digital zugänglich gemacht und international vernetzt werden? Das österreichische Konsortium OSCA (Open Scientific Collections AUT) lädt dazu vom 11.–12.09.25 ins NHM Wien zum zweitägigen Treffen ein. Mehr: tinyurl.com/3hc7va4s #nhmwien

Over 220 participants from more than 130 organizations have already registered for #REG25! Join us in Vienna on 15.10. for an update on MDR, IVDR, etc. Startups: This a door-opener to the regulatory universe, especially if your product’s classification isn’t yet clear. mailchi.mp/lisavienna/r...

The Vienna BioCenter PhD program in Molecular BioSciences will offer 20+ fully-funded positions in the Autumn Call which is now open. Have a look at what our campus has to offer: www.vbcphd.at

We are looking forward to a panel discussion on software tools for supporting regulatory affairs at #REG25, Oct 15 in Vienna - Alexander Fink, Metecon - Sophie Pingitzer, XUND - Birgit Wahlmüller, MADx - Andreas Weinfurter, ACMIT Moderation: Martin Schmid, en.co.tec www.linkedin.com/feed/update/...

Learn more about leveraging real-world data for clinical development of MD at #REG25, 15.10. in Vienna: Ghazaleh Gouya: How to use RWD for generating clinical evidence Camille Petri: The Notified Body’s perspective Katarzyna Malenczyk: Lessons from mySugr's PMCF plan www.linkedin.com/feed/update/...

The Vienna BioCenter PhD program in Molecular BioSciences will offer 20+ fully-funded positions in the Autumn Call which is now open. Please share. Further details: www.vbcphd.at

📌 125 Jahre #Medizinstudium für #Frauen in #Österreich Gestern präsentierte Birgit Kofler-Bettschart ihr Buch über die Pionierinnen der Medizin – Frauen, die Hürden überwanden und Geschichte schrieben. 💪👩‍⚕️ 📸 Eindrücke vom Abend ➜ https://bit.ly/47ptzEy

15.10. #REG25: From theory to reality - Friederike Windisch | Nina Zimmermann @goeg.at: Transition to MDR/IVDR: status quo of economic operators - Monika Hupfauf | Martin Popovic: Regulatory Fork in the Road: US or EU First? Pros and Cons www.linkedin.com/feed/update/...

15.10.2025: #REG25 in Vienna | Sssion A2: Regulatory aspects around trustworthy #AI - 11:00 Ali Moshayedi, BSI: Compliance and Trust Under The EU AI Act - 11:40 Diether Kramer, Predicting Health: Mind the Risk: Bringing Clinical Risk Prediction into Compliance. www.linkedin.com/feed/update/...

Apply by September 11 to join Takeda's R&D Science Day 2025 on October 16 in Vienna! -> Opportunity for innovators, start-ups, spin-offs, subject matter experts, and application-oriented academic researchers focusing e.g. on bioprocesses, AI and formulation www.linkedin.com/feed/update/...

Apply by 28.10.: Houska Prize, Austria's largest private award for applied research 3 categories: - University Research - Non-University Research - R&D in SMEs Each: 1. Prize €150,000 2. Prize €70,000 3. Prize €30,000 Across all categories: Mariella Schurz Prize €10,000 bcgruppe.at/en/houska-pr...

Vienna, 11.9.2025: W-HIT breakfast with Clara Neppel, Senior Director IEEE, AI Governance Expert and Board Member, Fredrik Debong, DigitalHealth, Serial Entrepreneur (mySugr, hi.health), Investor, Founder and Partner of Nineteen Twenty-One, and Irene Fialka, INiTS www.eventbrite.at/e/ai-and-the...

Enjoy the latest edition of LISAvienna’s newsletter! Inside, you’ll find highlights from regional companies and research institutions, an overview of current funding opportunities, and a preview of upcoming events you may want to join. www.linkedin.com/feed/update/...

BOKU University in Vienna is recruiting a full professor for Biochemistry! Check out the description below, apply and join us in beautiful Vienna. @bokuvienna.bsky.social 🧪🧪🧪 short.boku.ac.at/53e6g6

Learn more about regulatory aspects associated with IVD at LISAvienna's #REG25 conference, 15.10.2025, in Vienna: - QMD Services: Overcoming certification hurdles - MedUni Vienna: Best practice on in-house IVDs - MADx: Lessons learned from a company's perspective www.linkedin.com/feed/update/...

Register now to join the SLAS Regional Meet-Up on September 23, 2025 at the @viennabiocenter.bsky.social! www.linkedin.com/posts/lisavi...

📣 ESCMID is creating a brand-new #Vaccines Subcommittee! 💉We are looking for a director who will be responsible for establishing this new subcommittee. Interested persons can review the call document and apply by 31 Aug 2025: ow.ly/19nt50WI2Ss#Vaccines #IDSky #clinmicro #MedSky

Opportunity for SMEs in our network looking to recruit top talent in Vienna: “NaturTalente,” @univie.ac.at's Life Science High Potential Program, is offering a free slot to one SME from the life sciences sector. To express your interest, reach out to Joyce Fasan. www.uniport.at/naturtalente

New funding initiative launched at aws: Innovation Protection for Key Technologies such as #AI, #robotics or #lifesciences at #startup companies and #SMEs with grants of up to EUR 75,000. www.linkedin.com/feed/update/...

LISAvienna Regulatory Affairs Conference for Medical Devices and In-vitro Diagnostics, Vienna, 15.10.2025: Partnering is now open: Start to request 20-minute-meetings with conference participants to boost your network at #REG25! mailchi.mp/lisavienna/r...

Congratulations to Boehringer Ingelheim: A compound developed in Vienna, Austria, to treat a specific form of lung cancer has been approved in the U.S. This is a great achievement not only for the company but also for Vienna as a center for precision oncology. www.linkedin.com/feed/update/...

Je früher ein Tumor behandelt wird, desto höher sind die Chancen auf Heilung futurezone.at/science/ki-k...

📣 Call for expression of interest: Join EMA's first Scientific Advisory Group on Immune and Inflammatory Diseases. Mandate duration: 3 years, upon the Committee for Medicinal Products for Human Use (CHMP) appointment. Find out more now 👉 lnkd.in/eXXHv5nb

🗓️ @mylliabio.bsky.social sponsors the first conference on "High-Content CRISPR Screening" from March 18-19, 2026 in Vienna: perturb2026.bio Scientific topics: 🔬 CRISPR-based screening strategies 🧬 Perturb-Seq & CROP-Seq 💻 Computational analyses 💻 AI models of human cells 📸 Image-based screens

Learn more about cybersecurity and IT security for medical devices - Larissa Naber (Proregia), Tina Vodopivec (SIQ Ljubljana), and Nilaykumar Patel (contextflow) will provide insights at this year's #REG25 conference in Vienna. Register by 8.8. to save costs! www.linkedin.com/posts/lisavi...

📣Open call ESCMID is creating a brand-new #Vaccines Subcommittee. 💉 We are now looking for a director who will be responsible for establishing this new subcommittee. Interested persons can review the call document and apply before 31 August 2025. ☝️www.escmid.org/about...#Vaccines #IDSky #clinmicro

In Vienna, life sciences activity is woven into the fabric of the entire city. At several geographic clusters research and entrepreneurship thrive side by side. Efficient public transport ensures that these hotspots are well-connected – typically within 45 minutes. www.linkedin.com/feed/update/...

Learn more about post market surveillance und PSUR at LISAvienna's #REG25 conference on October 15 in Vienna! Early bird rates are still available until August 8. More than 160 participants have already registered. Partnering request will be possible as of August 18. www.linkedin.com/feed/update/...

Did you know that the world’s top 20 biotechnology, pharmaceutical, and medical device companies by 2023 sales have established commercial offices in the Vienna region? Some also operate manufacturing sites, and many conduct clinical trials here - learn more! www.linkedin.com/feed/update/...